search
Back to results

Comparing the Effects of Exercise on the Structure and Function of Fat Tissue (CAT)

Primary Purpose

Adiposity

Status
Enrolling by invitation
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Oral Glucose Tolerance Test
Sponsored by
University of Michigan
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Adiposity

Eligibility Criteria

18 Years - 40 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Age: 18-40 years old
  • Body Mass Index: 23-35 kg/m2
  • Women must have regularly occurring menses and must be premenopausal

Exclusion Criteria:

  • Evidence/history of cardiovascular or metabolic disease
  • Medications known to affect lipid or glucose metabolism, or inflammation
  • Weight instability ≥ ± 6 pounds in the last 6 months
  • Tobacco or e-cigarette users
  • Women must not be pregnant or actively lactating
  • Blood pressure > 140/90 mmHg

Sites / Locations

  • University of Michigan

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Oral Glucose Tolerance Test

Arm Description

Subjects will complete an Oral Glucose Tolerance Test in which glucose is given and blood samples are taken every 15 minutes over a 2 hour period to determine how quickly the glucose is cleared from the blood.

Outcomes

Primary Outcome Measures

Blood Glucose Level
mg/dL
Adipose tissue fibrosis
Pico-sirius Red stain (percent stained)

Secondary Outcome Measures

Full Information

First Posted
April 7, 2022
Last Updated
June 15, 2023
Sponsor
University of Michigan
search

1. Study Identification

Unique Protocol Identification Number
NCT05328570
Brief Title
Comparing the Effects of Exercise on the Structure and Function of Fat Tissue
Acronym
CAT
Official Title
Effects of Exercise Training on the Structure and Metabolic Function of Fat Tissue
Study Type
Interventional

2. Study Status

Record Verification Date
June 2023
Overall Recruitment Status
Enrolling by invitation
Study Start Date
June 4, 2020 (Actual)
Primary Completion Date
September 2025 (Anticipated)
Study Completion Date
September 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Michigan

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Assess differences in structure and biological function of abdominal subcutaneous adipose tissue samples collected from adults who exercise regularly vs. a well-matched cohort of non-exercisers.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Adiposity

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
50 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Oral Glucose Tolerance Test
Arm Type
Experimental
Arm Description
Subjects will complete an Oral Glucose Tolerance Test in which glucose is given and blood samples are taken every 15 minutes over a 2 hour period to determine how quickly the glucose is cleared from the blood.
Intervention Type
Diagnostic Test
Intervention Name(s)
Oral Glucose Tolerance Test
Intervention Description
Subjects will complete an Oral Glucose Tolerance Test in which glucose is given and blood samples are taken every 15 minutes over a 2 hour period to determine how quickly the glucose is cleared from the blood.
Primary Outcome Measure Information:
Title
Blood Glucose Level
Description
mg/dL
Time Frame
2 hours at Experimental Trial
Title
Adipose tissue fibrosis
Description
Pico-sirius Red stain (percent stained)
Time Frame
baseline

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Age: 18-40 years old Body Mass Index: 23-35 kg/m2 Women must have regularly occurring menses and must be premenopausal Exclusion Criteria: Evidence/history of cardiovascular or metabolic disease Medications known to affect lipid or glucose metabolism, or inflammation Weight instability ≥ ± 6 pounds in the last 6 months Tobacco or e-cigarette users Women must not be pregnant or actively lactating Blood pressure > 140/90 mmHg
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jeffrey F Horowitz, PhD
Organizational Affiliation
University of Michigan
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Michigan
City
Ann Arbor
State/Province
Michigan
ZIP/Postal Code
48109
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Comparing the Effects of Exercise on the Structure and Function of Fat Tissue

We'll reach out to this number within 24 hrs